Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage HCC

Condition:   Hepatocellular Carcinoma Interventions:   Drug: Anti-PD-1/PD-L1;   Drug: S-Adenosyl-Methionine Sponsor:   Shanghai Zhongshan Hospital Recruiting

Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials